Table 3.
Comorbidities in IBS patients vs. controls.
IBS | Control | IBS vs. Control, Odds Ratio (95%CI) | P-Value | IBS diagnosed by GI* | IBS diagnosed by non-GI* | IBS diagnosed by GI vs. non-GI, Odds Ratio (95%CI) | P-Value | |
---|---|---|---|---|---|---|---|---|
Other Pain Syndromes | ||||||||
Migraine | 51,886 (36.7%) | 28,380 (20.1%) | 2.31 (2.27–2.35) | <0.0001 | 6,108 (41.7%) | 37,534 (36.7%) | 1.23 (1.19–1.28) | <0.0001 |
Fibromyalgia | 8,288 (5.9%) | 1,900 (1.3%) | 4.57 (4.35–4.81) | <0.0001 | 1,179 (8.1%) | 6,070 (5.9%) | 1.39 (1.30–1.48) | <0.0001 |
Chronic Pain | 26,467 (18.7%) | 10,568 (7.5%) | 2.85 (2.78–2.92) | <0.0001 | 3,781 (25.8%) | 19,217 (18.8%) | 1.50 (1.44–1.56) | <0.0001 |
Psychiatric Comorbidities | ||||||||
Anxiety | 51,452 (36.4%) | 21,724 (15.4%) | 3.15 (3.10–3.21) | <0.0001 | 5,745 (39.2%) | 37,773 (37.0%) | 1.10 (1.06–1.14) | <0.0001 |
Depression | 55,117 (39.0%) | 27,507 (19.5%) | 2.65 (2.60–2.69) | <0.0001 | 6,308 (43.1%) | 39,994 (39.1%) | 1.18 (1.14–1.22) | <0.0001 |
Bipolar | 4,585 (3.2%) | 1,894 (1.3%) | 2.47 (2.34–2.61) | <0.0001 | 594 (4.1%) | 3,261 (3.2%) | 1.28 (1.17–1.40) | <0.0001 |
Psychosis | 662 (0.5%) | 379 (0.3%) | 1.75 (1.54–1.99) | <0.0001 | 106 (0.7%) | 463 (0.5%) | 1.60 (1.30–1.98) | <0.0001 |
Other Medical Diagnoses | ||||||||
Diabetes | 13,558 (9.6%) | 14,730 (10.4%) | 0.91 (0.89–0.93) | <0.0001 | 1,759 (12.0%) | 9,643 (9.4%) | 1.31 (1.24–1.38) | <0.0001 |
Celiac Disease | 136 (0.1%) | 26 (0.0%) | 5.23 (3.44–7.96) | <0.0001 | 28 (0.2%) | 100 (0.1%) | 1.96 (1.29–2.98) | 0.0014 |
Crohn's Disease | 954 (0.7%) | 221 (0.2%) | 4.34 (3.75–5.02) | <0.0001 | 313 (2.1%) | 499 (0.5%) | 4.45 (3.86–5.13) | <0.0001 |
Colitis | 2,723 (1.9%) | 774 (0.5%) | 3.57 (3.29–3.87) | <0.0001 | 685 (4.7%) | 1,577 (1.5%) | 3.13 (2.86–3.43) | <0.0001 |
Inflammatory Bowel Disease | 1,560 (1.1%) | 246 (0.2%) | 6.40 (5.59– 7.32) | <0.0001 | 373 (2.5%) | 937 (0.9%) | 2.83 (2.50–3.19) | <0.0001 |
IBS: Irritable bowel syndrome; GI: gastroenterologist; SD: Standard deviation; NA: Not applicable
Provider specialty known for 83% of IBS patients